menu
    • menu

    Company profile for Silence Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using its enabling delivery systems, it has achieved an additional level of specificity by delivering its therapeutic RNA mole...
    Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using its enabling delivery systems, it has achieved an additional level of specificity by delivering its therapeutic RNA molecules exclusively to target cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Silence Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    72 Hammersmith Road, London
    Telephone
    Telephone
    +44 (0)20 3457 6900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.silence-therapeutics.com/home/default.aspx
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Silence Therapeutics Announces Leadership Changes
    Silence Therapeutics Announces Leadership Changes

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215323930/en/Silence-Therapeutics-Announces-Leadership-Changes

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Silence Therapeutics Joins Chat at Jefferies Health Conference
    Silence Therapeutics Joins Chat at Jefferies Health Conference

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112215352/en/Silence-Therapeutics-to-Participate-in-Fireside-Chat-at-Jefferies-Global-Healthcare-Conference

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Silence Therapeutics Unveils Q3 2025 Financials & Business Update
    Silence Therapeutics Unveils Q3 2025 Financials & Business Update

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106177990/en/Silence-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Silence Therapeutics Completes Enrollment in SANRECO Ph 2 Study
    Silence Therapeutics Completes Enrollment in SANRECO Ph 2 Study

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251023681567/en/Silence-Therapeutics-Completes-Enrollment-in-SANRECO-Phase-2-Study-of-Divesiran-for-Polycythemia-Vera-PV

    BUSINESSWIRE
    23 Oct 2025
    Share Share
    Silence Therapeutics Q2 Financial Results and Business Highlights
    Silence Therapeutics Q2 Financial Results and Business Highlights

    07 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250807436715/en/Silence-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

    BUSINESSWIRE
    07 Aug 2025
    Share Share
    Silence Highlights Ph1 Divesiran Data for Polycythemia Vera
    Silence Highlights Ph1 Divesiran Data for Polycythemia Vera

    12 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250612873071/en/Silence-Therapeutics-Presents-Additional-Phase-1-Data-Highlighting-Promise-of-Divesiran-as-the-Potential-First-in-Class-siRNA-Treatment-for-Polycythemia-Vera

    BUSINESSWIRE
    12 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search